The novel therapy of this peptide represents a significant advance in the care of the condition. Different to existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide109068.bloggactivo.com/41109921/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment